Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.

Autor: Eholie SP; Université Félix Houphouët-Boigny, Département de Dermatologie et d'Infectiologie, UFR des Sciences Médicales, Abidjan, Côte d'Ivoire; Centre Hospitalier Universitaire de Treichville Service des Maladies Infectieuses et Tropicales, Abidjan, Côte d'Ivoire; Programme PACCI, Abidjan, Côte d'Ivoire., Ekouevi DK; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France; Centre Africain de Recherche en Epidémiologie et en Santé Publique, Lomé, Togo; Université de Lomé, Département Santé Publique, Lomé, Togo., Chazallon C; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Charpentier C; Service de virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France., Messou E; Centre de Prise en Charge et de Formation (CePReF), Abidjan, Côte d'Ivoire., Diallo Z; Université Félix Houphouët-Boigny, Département de Dermatologie et d'Infectiologie, UFR des Sciences Médicales, Abidjan, Côte d'Ivoire; Centre Hospitalier Universitaire de Treichville Service des Maladies Infectieuses et Tropicales, Abidjan, Côte d'Ivoire; Programme PACCI, Abidjan, Côte d'Ivoire., Zoungrana J; Service des Maladies Infectieuses et Tropicales, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Minga A; Centre Médical de Suivi des Donneurs de Sang (CMSDS-CNTSCI), Abidjan, Côte d'Ivoire., Ngom Gueye NF; Service des Maladies Infectieuses et Tropicales, CHNU Fann, Dakar, Sénégal., Hawerlander D; Centre Intégré de Recherches Biocliniques d'Abidjan (CIRBA) Abidjan, Côte d'Ivoire., Dembele F; Unité de soins ambulatoires et de conseil (USAC), CHU de Treichville, Abidjan, Côte d'Ivoire., Colin G; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Tchounga B; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Karcher S; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Le Carrou J; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Tchabert-Guié A; Programme PACCI, Abidjan, Côte d'Ivoire., Toni TD; Programme PACCI, Abidjan, Côte d'Ivoire; CeDReS, Centre Hospitalier Universitaire de Treichville, Abidjan, Côte d'Ivoire., Ouédraogo AS; Unité de Virologie, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Bado G; Unité de Virologie, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Toure Kane C; Laboratoire de Bacteriologie, Virologie, CHU Le Dantec, Dakar, Sénégal., Seydi M; Service des Maladies Infectieuses et Tropicales, CHNU Fann, Dakar, Sénégal., Poda A; Service des Maladies Infectieuses et Tropicales, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Mensah E; ONG espoir Vie Togo, Cente Medico-social, Licia Lomé, Togo., Diallo I; Service de Médecine Interne, CHU Yalgado OUEDRAOGO, Ouagadougou, Burkina Faso., Drabo YJ; Service de Médecine Interne, CHU Yalgado OUEDRAOGO, Ouagadougou, Burkina Faso., Anglaret X; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France. Electronic address: xavier.anglaret@u-bordeaux.fr., Brun-Vezinet F; Service de virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.

Publikováno v: The lancet. HIV [Lancet HIV] 2024 Jun; Vol. 11 (6), pp. e380-e388. Date of Electronic Publication: 2024 May 10.

Future of HIV2 and HIV2 +  1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015.

Autor: Diallo I; Department of Internal Medicine/Day Hospital (HIV Department), Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso.; Training and Research Unit Health Sciences (UFR-SDS), Joseph KI-Zerbo University, Ouagadougou, Burkina Faso., Ouédraogo S; Training and Research Unit Health Sciences (UFR-SDS), Joseph KI-Zerbo University, Ouagadougou, Burkina Faso.; Public Health Department, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso., Sawadogo A; Department of Infectious Diseases, Regional Teaching Hospital of Ouahigouya, Ouahigouya, Burkina Faso., Ouédraogo GA; Department of Infectious Diseases, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso., Diendéré EA; Department of Internal Medicine, Teaching Hospital of Bogodogo, Ouagadougou, Burkina Faso., Zoungrana J; Superior Institute of Health Sciences, Department of infectious diseases and tropical medicine, Nazi Boni University, Bobo Dioulasso, Burkina Faso., Sondo AK; Training and Research Unit Health Sciences (UFR-SDS), Joseph KI-Zerbo University, Ouagadougou, Burkina Faso.; Department of Infectious Diseases, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso., Bognounou R; Department of Internal Medicine/Day Hospital (HIV Department), Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso., Savadogo M; Training and Research Unit Health Sciences (UFR-SDS), Joseph KI-Zerbo University, Ouagadougou, Burkina Faso.; Department of Infectious Diseases, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso., Poda A; Superior Institute of Health Sciences, Department of infectious diseases and tropical medicine, Nazi Boni University, Bobo Dioulasso, Burkina Faso., Drabo YJ; Department of Internal Medicine/Day Hospital (HIV Department), Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso.; Training and Research Unit Health Sciences (UFR-SDS), Joseph KI-Zerbo University, Ouagadougou, Burkina Faso.

Publikováno v: Journal of the International Association of Providers of AIDS Care [J Int Assoc Provid AIDS Care] 2022 Jan-Dec; Vol. 21, pp. 23259582221143675.

Roles et taches des accompagnateurs des patients hospitalises dans le service de pneumo-phtysiologie au Centre Hospitalier Universitaire Yalgado Ouedraogo de Ouagadougou (Burkina Faso)

Autor: Ouedraogo, SM, Sondo, KA, Kyelem, CG, Sanou, Y, Badoum, G, Ouedraogo, M, Drabo, YJ

Publikováno v: Science et Technique, Sciences de la Santé; Vol 37, No 1-2 (2014); 57-66

La penurie en ressources humaines de sante est un pbenomene universe! et 1' Afrique n'est pas en reste. Cette etude vise a etudier les types de soutien apporte par l'accompagnateur des patients hospitalises et les taches qui leur sont assignees dans

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::92ec71b98d77b0633d99a901560853da
https://www.ajol.info/index.php/stss/article/view/141171

[Prevalence of Diabetes and Diabetes-Related Cardiovascular Risk Factors in a Rural Population in Burkina Faso].

Autor: Séré L; Centre hospitalier universitaire de Tengandogo, Ouagadougou, Burkina Faso., Tiéno H; Centre hospitalier universitaire de Bogodogo, Ouagadougou, Burkina Faso., Yanogo D; Centre hospitalier universitaire de Tengandogo, Ouagadougou, Burkina Faso., Traoré S; Centre hospitalier universitaire de Tengandogo, Ouagadougou, Burkina Faso.; Centre hospitalier universitaire de Bogodogo, Ouagadougou, Burkina Faso.; Centre hospitalier universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso., Nagabila Y; Centre hospitalier universitaire de Tengandogo, Ouagadougou, Burkina Faso., Ouédraogo DD; Centre hospitalier universitaire de Bogodogo, Ouagadougou, Burkina Faso., Drabo YJ; Centre hospitalier universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.

Publikováno v: Medecine tropicale et sante internationale [Med Trop Sante Int] 2021 Feb 12; Vol. 1 (1). Date of Electronic Publication: 2021 Feb 12 (Print Publication: 2021).

Prevalence of HIV infection among the patients with an avascular necrosis of the femoral head in Ouagadougou, Burkina Faso

Autor: Ouédraogo, DD, Ouédraogo, T, Kaboré, F, Kafando, H, Zan, A, Bognounou, R, Drabo, YJ

Publikováno v: African Journal of Rheumatology; Vol 1, No 2 (2013); 57-60

Objective: To study the prevalence of HIV infection among the risk factors associated with the avascular necrosis of the femoral head in Ouagadougou, Burkina Faso. Design: Multicenter retrospective study. Setting: Rheumatology consultations and Ortho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::f383b38d03c852bd83c5e206533df0d1
https://www.ajol.info/index.php/ajr/article/view/97421